Bausch & Lomb Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
31
About the Report
About the Report
Summary
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.
Bausch & Lomb Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Bausch & Lomb Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bausch & Lomb Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Devices Deals, 2012 to YTD 2018 9
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 11
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 12
Bausch & Lomb Enters Into Licensing Agreement With Eye Therapies For Technology To Treat Ocular Redness 13
Equity Offering 14
Bausch & Lomb Withdraws IPO 14
Acquisition 16
Valeant Pharma Completes Acquisition Of Bausch & Lomb For USD 8.7 Billion 16
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 18
Bausch & Lomb Completes Acquisition Of ISTA Pharma For USD 500 Million 20
Bausch & Lomb Inc-Key Competitors 22
Bausch & Lomb Inc-Key Employees 23
Bausch & Lomb Inc-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Corporate Communications 26
Aug 20, 2018: Joseph Gordon Named U.S. President of Bausch + Lomb 26
Legal and Regulatory 27
Jan 17, 2017: Bausch + Lomb Successfully Defends Patent Covering PreserVision Eye Vitamins in Case vs. Vitamin Health 27
Product News 28
Jun 14, 2018: Bausch + Lomb Announces US Launch of Soothe Xtra Protection Preservative Free Lubricant Eye Drops 28
Feb 21, 2018: New glaucoma drugs yield large, lasting reductions in intraocular pressure 29
Other Significant Developments 30
Jul 17, 2017: Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Figure
List of Figures
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Key Facts 2
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bausch & Lomb Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bausch & Lomb Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Bausch & Lomb Inc, Medical Devices Deals, 2012 to YTD 2018 9
Bausch & Lomb Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 11
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 12
Bausch & Lomb Enters Into Licensing Agreement With Eye Therapies For Technology To Treat Ocular Redness 13
Bausch & Lomb Withdraws IPO 14
Valeant Pharma Completes Acquisition Of Bausch & Lomb For USD 8.7 Billion 16
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 18
Bausch & Lomb Completes Acquisition Of ISTA Pharma For USD 500 Million 20
Bausch & Lomb Inc, Key Competitors 22
Bausch & Lomb Inc, Key Employees 23
Bausch & Lomb Inc, Other Locations 24
Bausch & Lomb Inc, Subsidiaries 25
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.